Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v14-EN Version v13-FR
Language English French
Date Updated 2019-01-12 2019-01-11
Drug Identification Number 02415968 02415968
Brand name REPAGLINIDE REPAGLINIDE
Common or Proper name REPAGLINIDE REPAGLINIDE
Company Name PRO DOC LIMITEE PRO DOC LIMITEE
Ingredients REPAGLINIDE REPAGLINIDE
Strength(s) 0.5MG 0.5MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 100 100
ATC code A10BX A10BX
ATC description BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date
Actual start date 2018-11-15 2018-11-15
Estimated end date
Actual end date 2019-01-11 2019-01-11
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments